Altimmune has a total of 229 patents globally, out of which 93 have been granted. Of these 229 patents, more than 61% patents are active. The United States of America is where Altimmune has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Altimmune.
Altimmune was founded in 1997 by De Chu Christopher Tang. Altimmune operates as a clinical stage immunotherapeutic biotechnology company. The Company discovers and develops novel products that engage, stimulate, and improve immune response for the prevention and treatment of acute respiratory and chronic viral infections and cancer. Altimmune serves patients worldwide. As of September 2022, Altimmune has a market cap of $ 1.09Billion.
Do read about some of the most popular patents of Altimmune which have been covered by us in this article and also you can find Altimmune patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Altimmune patent portfolio.
How many patents does the Founder and CEO of Altimmune have?
The founder De Chu Christopher Tang has 10 patents CEO Wayne Pisano has 0 patents.
How many patents does Altimmune have?
Altimmune has a total of 229 patents globally. These patents belong to 49 unique patent families. Out of 229 patents, 140 patents are active.
How Many Patents did Altimmune File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Altimmune Applications Filed | Altimmune Patents Granted |
| 2011 | 14 | – |
| 2012 | 21 | 3 |
| 2013 | 17 | 2 |
| 2014 | 26 | 5 |
| 2015 | 5 | 7 |
| 2016 | 5 | 6 |
| 2017 | 6 | 20 |
| 2018 | 6 | 6 |
| 2019 | 14 | 9 |
| 2020 | 23 | 7 |
| 2021 | 13 | 15 |
| 2022 | 2 | 11 |
How many Altimmune patents are Alive/Dead?
Worldwide Patents
How Many Patents did Altimmune File in Different Countries?
Countries in which Altimmune Filed Patents
| Country | Patents |
| United States Of America | 54 |
| Japan | 26 |
| Europe | 24 |
| Korea (South) | 23 |
| Canada | 16 |
| Australia | 10 |
| Germany | 8 |
| India | 7 |
| Spain | 7 |
| Israel | 6 |
| China | 5 |
| Denmark | 4 |
| Brazil | 3 |
| Mexico | 3 |
| Eurasia | 2 |
| Hong Kong (S.A.R.) | 2 |
| South Africa | 1 |
| Poland | 1 |
| Taiwan | 1 |
| Argentina | 1 |
Where are Research Centers of Altimmune Patents Located?
10 Best Altimmune Patents
US20060253913A1 is the most popular patent in the Altimmune portfolio. It has received 95 citations so far from companies like Ngm Biopharmaceuticals, Inc, Caribou Biosciences Inc, and Human Genome Sciences Inc.
Below is the list of 10 most cited patents of Altimmune:
| Publication Number | Citation Count |
| US20060253913A1 | 95 |
| US20060039870A1 | 41 |
| US20070178115A1 | 31 |
| US7687455B2 | 27 |
| US20130071394A1 | 26 |
| US20050271689A1 | 15 |
| WO2008019036A2 | 14 |
| US20110268762A1 | 13 |
| US8129333B2 | 12 |
| WO2010084298A1 | 12 |
What Percentage of Altimmune US Patent Applications were Granted?
Altimmune (Excluding its subsidiaries) has filed 38 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 25 have been granted leading to a grant rate of 83.33%.
Below are the key stats of Altimmune patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Altimmune?
| Law Firm | Total Applications | Success Rate |
| Duane Morris Llp | 30 | 95.65% |
| Koren Anderson | 3 | 50.00% |
| Vedder Price PC | 2 | 50.00% |
| Goodwin Procter Llp | 1 | 0.00% |
| Mckee Voorhees & Sease Plc | 1 | 100.00% |
| Thomas J Kowalski | 1 | 0.00% |
EXCLUSIVE INSIGHTS COMING SOON!